Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
49.00
0.00 (0.00%)
Nov 18, 2026, 10:14 AM JST
TYO:4596 Revenue
Kubota Pharmaceutical Holdings had revenue of 3.00M JPY in the quarter ending September 30, 2026, a decrease of -45.03%. This brings the company's total for the last twelve months to 12.77M, down -54.84% year-over-year. In the year 2025, Kubota Pharmaceutical Holdings had annual revenue of 21.00M, down -22.22%. That makes Kubota Pharmaceutical Holdings the 46,269th largest company in the world by revenue and 3,876th in Japan.
Revenue (ttm)
12.77M
Revenue Growth
-54.84%
P/S Ratio
622.41
Revenue / Employee
n/a
Employees
8
Market Cap
7.95B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.00M | -6.00M | -22.22% |
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 5.79B |
| StemCell Institute | 2.81B |
| Immuno-Biological Laboratories | 1.08B |
| AnGes | 979.00M |
| Carna Biosciences | 756.57M |
| Nano Holdings | 210.00M |
| CellSeed | 161.00M |
| ADR Biomedical Holdings | 98.00M |